Edulan, Necky Jane A.

HRN: 22-19-88  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/17/2022
11/24/2022
IVTT
180mg
Q8h
Intestinal Amoebiasis
Waiting Final Action 
11/17/2022
AMPICILLIN 1GM (VIAL)
11/17/2022
11/24/2022
IVTT
450mg
Q8h
UTI
Waiting Final Action 
11/18/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
11/18/2022
11/23/2022
PO
7.5ml
TID
Intestinal Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: